Browse hierarchy: [Microbiology (MI)](/submissions/MI) → [Subpart D — Serological Reagents](/submissions/MI/subpart-d%E2%80%94serological-reagents) → [21 CFR 866.3125](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3125) → GTF — Antisera, Bethesda - Ballerup Polyvalent, Citrobacter Spp.

# GTF · Antisera, Bethesda - Ballerup Polyvalent, Citrobacter Spp.

_Microbiology · 21 CFR 866.3125 · Class 1_

**Canonical URL:** https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GTF

## Overview

- **Product Code:** GTF
- **Device Name:** Antisera, Bethesda - Ballerup Polyvalent, Citrobacter Spp.
- **Regulation:** [21 CFR 866.3125](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3125)
- **Device Class:** 1
- **Review Panel:** [Microbiology](/submissions/MI)

## Identification

Citrobacter spp. serological reagents are devices that consist of antigens and antisera used in serological tests to identify Citrobacter spp. from cultured isolates derived from clinical specimens. The identification aids in the diagnosis of disease caused by bacteria belonging to the genus Citrobacter and provides epidemiological information on diseases caused by these microorganisms. Citrobacter spp. have occasionally been associated with urinary tract infections.

## Classification Rationale

Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 866.9.

## Recent Cleared Devices (0 of 0)

_No cleared devices on record._

---

**Source:** [https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GTF](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GTF)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com